REGENXBIO Inc. (RGNX:NASDAQ) rocketted at $43.4, a gain of 31.2%. The stock got featured on our News Catalysts scanner on Mon, Sep 13, 2021 at 12:56 PM in the 'PATNERSHIP' category. From Fri, Aug 27, 2021, the stock recorded 55.56% Up Days and 60.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About REGENXBIO Inc. (RGNX:NASDAQ)
Regenxbio Inc is a biotechnology company. It is engaged in the development, commercialization and licensing of recombinant adeno-associated virus gene therapy.
Top 10 Gainers:
- aTyr Pharma, Inc. (LIFE:NASDAQ), 66.97%
- ATER (ATER:NASDAQ), 52.37%
- Itamar Medical Ltd. (ITMR:NASDAQ), 45.22%
- iRhythm Technologies, Inc. (IRTC:NASDAQ), 35%
- TMC (TMC:NASDAQ), 32.31%
- REGENXBIO Inc. (RGNX:NASDAQ), 31.2%
- Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT), 27.12%
- UROY (UROY:NASDAQ), 24.29%
- Mayville Engineering Company, Inc. (MEC:NYSE), 24.28%
- BELLUS Health Inc. (BLU:NASDAQ), 21.94%